Cortical layer 2/3 interneurons play a critical role in the pathophysiology of schizophrenia, representing a key cellular substrate for the inhibitory deficits that characterize this disorder. Layer 2/3 constitutes a pivotal cortical lamina where sensory integration, intracortical processing, and feedforward signaling converge. The GABAergic interneurons within this layer, particularly those expressing parvalbumin (PV) and somatostatin (SST), undergo substantial alterations in schizophrenia that contribute to the characteristic deficits in gamma oscillations, working memory, and sensory processing. [@lewis2014]
The laminar organization of the neocortex positions layer 2/3 as a critical hub for horizontal connectivity and integration across cortical columns. This position makes L2/3 interneurons particularly important for coordinating neuronal ensembles and generating the synchronized activity patterns that underlie cognitive processes. In schizophrenia, these coordination mechanisms fail, leading to the fragmented thinking and perceptual disturbances that define the disorder. [@gonzalez2013]
Layer 2/3 contains several distinct interneuron populations, each with unique molecular markers, electrophysiological properties, and synaptic targets:
Parvalbumin (PV)-expressing interneurons:
- Fast-spiking basket cells targeting pyramidal neuron somata and proximal dendrites
- Chandelier cells targeting pyramidal neuron axon initial segments
- Account for approximately 40% of cortical GABAergic neurons
- Critical for gamma oscillation generation (30-80 Hz)
- Show robust alterations in schizophrenia
Somatostatin (SST)-expressing interneurons:
- Martinotti cells targeting distal dendrites
- Regular-spiking non-pyramidal cells
- Regulate input integration and local inhibition
- Contribute to feedback inhibition circuits
- Also significantly affected in schizophrenia
Vasoactive intestinal peptide (VIP)-expressing interneurons:
- Disinhibition through inhibition of other interneurons
- Role in attention and novelty detection
- Less studied in schizophrenia but potentially relevant
Layer 2/3 interneurons display diverse morphologies:
| Cell Type |
Morphology |
Target |
Function |
| PV basket cells |
Multipolar, dense axonal arbor |
Perisomatic |
Strong inhibition |
| PV chandelier cells |
Vertical axonal cartridges |
Axon initial segment |
Control output |
| SST Martinotti cells |
Bitufted, ascending dendrites |
Distal dendrites |
Input regulation |
| VIP cells |
Bipolar, elongated |
Interneurons |
Disinhibition |
Schizophrenia is associated with robust transcriptional alterations in GABAergic signaling molecules in layer 2/3:
Glutamic acid decarboxylase (GAD):
- GAD1 (GAD67) mRNA reduced by 30-50% in prefrontal cortex L2/3
- GAD2 (GAD65) also show alterations
- Level of reduction correlates with clinical severity
- Underlies impaired GABA synthesis [@fung2010]
GABA receptor subunits:
- GABRA1 (α1 subunit) expression reduced
- GABRB2 (β2 subunit) decreased
- Altered receptor composition affects synaptic inhibition
- Contributing to disinhibition in cortical circuits [@hashimoto2008]
Parvalbumin-specific alterations:
- PV mRNA and protein levels significantly reduced
- Expression of PV-related transcription factors (ER81, Npas1) altered
- PV neurons show reduced somatic size in schizophrenia
- Represents a specific molecular signature of the disorder [@Volk2012]
Genome-wide expression studies reveal:
-
Downregulated pathways:
- GABAergic signaling
- Synaptic transmission
- Potassium channel function
- Mitochondrial metabolism
-
Upregulated pathways:
- Immune-related genes
- Astrocyte markers
- Stress response genes
-
Cell-type specificity:
- PV neurons show greatest transcriptional disruption
- SST neurons show intermediate changes
- VIP neurons relatively spared
Layer 2/3 interneurons are essential for generating gamma oscillations (30-80 Hz), which are critical for:
- Working memory: Gamma synchrony during maintenance phase
- Attention: Filtering irrelevant stimuli
- Perception: Binding features into coherent objects
- Motor planning: Coordination of sensorimotor integration
In schizophrenia, gamma oscillations show characteristic deficits:
| Feature |
Normal |
Schizophrenia |
Functional Impact |
| Induced gamma |
Robust (30-50 μV) |
Attenuated (10-20 μV) |
Impaired perception |
| Task-related gamma |
Increased during load |
Absent or reduced |
Working memory deficits |
| Gamma phase-amplitude |
Coupled |
Decoupled |
Timing disruption |
| ITPC (induced) |
High |
Low |
Reduced synchrony |
These deficits in gamma activity directly correlate with the cognitive impairments that represent the core disability in schizophrenia. [@uhlhaas2013]
Layer 2/3 serves as the primary recipient of feedforward inhibition from layer 4. PV basket cells in L2/3 receive thalamic input and provide rapid inhibition to L2/3 pyramidal neurons, creating a precisely timed filtering mechanism. In schizophrenia:
- Thalamic inputs to PV neurons show reduced efficacy
- Feedforward inhibition timing is disrupted
- Pyramidal neurons receive insufficient inhibition
- Information flow through cortical columns becomes uncoordinated
SST-expressing Martinotti cells provide feedback inhibition to distal dendrites of L2/3 pyramidal neurons. This feedback circuit:
- Regulates the gain of pyramidal neuron responses
- Controls synaptic plasticity at feedback synapses
- Modulates receptive field properties
In schizophrenia, SST neuron dysfunction leads to:
- Enhanced dendritic excitability
- Altered synaptic integration
- Aberrant plasticity mechanisms
Presynaptic terminals:
- Reduced number of symmetric (GABAergic) synapses
- Altered vesicular GABA transporter (VGAT) expression
- Impaired GABA release probability
- Reduced frequency of miniature inhibitory currents (mIPSCs)
Terminal morphology:
- Smaller synaptic vesicles
- Reduced active zone size
- Altered postsynaptic density
GABAa receptor composition:
- Reduced α1 subunit containing receptors
- Increased α2 subunit containing receptors
- Altered receptor trafficking
- Reduced synaptic retention
Synaptic plasticity:
- Impaired inhibitory plasticity (LTP/LTD of inhibition)
- Altered spike timing-dependent plasticity
- Homeostatic plasticity failures
Layer 2/3 interneuron dysfunction correlates with core cognitive deficits:
Working memory impairment:
- Gamma oscillation deficits during maintenance
- Reduced PV neuron activity during delay
- Correlation with prefrontal cortical dysfunction
Attentional deficits:
- Impaired gamma-band synchronization during selective attention
- Reduced signal-to-noise ratio in cortical representations
- Related to frontoparietal network dysfunction
Perceptual organization:
- Gamma deficits affecting feature binding
- Impaired integration of visual elements
- Contributes to visual hallucinations
| Symptom Domain |
Interneuron Correlate |
Brain Region |
| Disorganized thinking |
PV deficits in PFC |
Prefrontal L2/3 |
| Auditory hallucinations |
Gamma abnormalities |
Superior temporal gyrus |
| Negative symptoms |
SST dysfunction |
Prefrontal cortex |
| Cognitive disorganization |
Network synchrony deficits |
Distributed |
Interneuron alterations in schizophrenia:
- Present at illness onset
- Progress over disease duration
- Correlate with duration of untreated illness
- May represent a neurodevelopmental component
Gray matter volume:
- Reduced thickness in prefrontal L2/3
- Layer-specific volume loss detected
- Correlates with PV expression deficits
Surface metrics:
- Altered curvature in superior frontal gyrus
- Reduced surface area in paracingulate region
- Related to symptom severity [@stedeh2017]
Task-related activation:
- Reduced activation during working memory
- Impaired deactivation during task demands
- Altered frontoparietal connectivity
Resting-state:
- Increased baseline activity in prefrontal cortex
- Reduced gamma connectivity
- Altered default mode network dynamics
Morphological findings:
- Reduced PV neuron density
- Decreased PV immunoreactivity
- Altered interneuron soma size
- Reduced synaptic contacts
Molecular findings:
- Reduced GAD67 expression
- Altered GABA receptor subunits
- Transcriptional dysregulation of PV genes [@curley2011]
Current medications:
- Antipsychotics primarily target dopaminergic and serotonergic receptors
- Indirect effects on GABAergic transmission
- Limited direct targeting of interneuron dysfunction
Emerging treatments:
- GABAa receptor positive allosteric modulators
- Metabotropic glutamate receptor agonists (mGluR5)
- Alpha-7 nicotinic receptor agonists
- Targeting PV deficits specifically
Transcranial magnetic stimulation (TMS):
- 40 Hz TMS may enhance gamma oscillations
- Targeting prefrontal cortex
- Potential for cognitive enhancement
Deep brain stimulation:
- Targeting prefrontal circuits
- Not currently established for schizophrenia
- Theoretical basis for interneuron modulation
Cognitive training:
- Working memory training may improve interneuron function
- Gamma-band auditory training
- Targeted cognitive remediation
Environmental enrichment:
- Promotes interneuron plasticity
- May enhance GABAergic function
- Adjunctive to pharmacological treatment
- Lewis DA et al., Cortical inhibition and the neurobiology of schizophrenia (2014)
- Gonzalez-Burgos G, Lewis DA, GABA neurons and the mechanisms of network oscillations (2013)
- Sohal VS, Rubenstein JLR, Excitation-inhibition balance as a framework for investigating mechanisms in neuropsychiatric disorders (2014)
- Marin O, Interneuron dysfunction in psychiatric disorders (2012)
- Stedeh F et al., Combining shape and surface based morphometry of superior frontal gyrus to differentiate schizophrenia and bipolar disorder (2017)
- Fung SJ et al., Expression of VGAT and GAD1 in schizophrenia and bipolar disorder (2010)
- Hashimoto T et al., Conserved regional patterns of GABA-related transcript expression in the prefrontal cortex of subjects with schizophrenia (2008)
- Volk DW et al., Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia (2012)
- Curley AA et al., Cortical deficits of parvalbumin expression in schizophrenia (2011)
- Uhlhaas PJ, Singer W, Aberrant synchronizations in schizophrenia (2013)